A new study published in the  Annals of Rheumatic Diseases found that rheumatoid arthritis (RA) patients treated after the advent of new drugs and management strategies had a longer survival rate than those treated earlier. The study, which looked at RA patients in the U.K. treated from 1999 to 2014, also found that co-morbidities did not significantly impact life span. These findings point to a reduction in rheumatoid arthritis disease activity and improved life longevity.

Click here for more.